Other
2027
Biogen 2027 remained flat by 0.0% to $485.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.4%, from $560.00M to $485.00M. Over 3 years (FY 2020 to FY 2023), 2027 shows an upward trend with a 18.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
How to read this metric
Lower projected expenses indicate a reduction in the drag on future net income as assets become fully amortized.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2027. These assets ty...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a31c97Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $215.00M | $255.00M | $255.00M | $210.00M | $210.00M | $215.00M | $215.00M | $195.00M | $200.00M | $325.00M | $345.00M | $565.00M | $565.00M | $510.00M | $560.00M | $565.00M | $485.00M | $485.00M |
| QoQ Change | — | +18.6% | +0.0% | -17.6% | +0.0% | +2.4% | +0.0% | -9.3% | +2.6% | +62.5% | +6.2% | +63.8% | +0.0% | -9.7% | +9.8% | +0.9% | -14.2% | +0.0% |
| YoY Change | — | — | — | — | -2.3% | -15.7% | -15.7% | -7.1% | -4.8% | +51.2% | +60.5% | +189.7% | +182.5% | +56.9% | -0.9% | +0.0% | -4.9% | -13.4% |
Range$195.00M – $565.00M
CAGR+21.1%
Avg YoY Growth+34.0%
Median YoY Growth-1.6%
2027 at Other Companies
Frequently Asked Questions
- What is Biogen's 2027?
- Biogen (BIIB) reported 2027 of $485.00M in Q1 2026.
- How has Biogen's 2027 changed year-over-year?
- Biogen's 2027 decreased by 13.4% year-over-year, from $560.00M to $485.00M.
- What is the long-term trend for Biogen's 2027?
- Over 3 years (2020 to 2023), Biogen's 2027 has grown at a 18.9% compound annual growth rate (CAGR), from $205.00M to $345.00M.
- What does 2027 mean?
- The expected non-cash expense for acquired intangible assets in the year 2027.